C-ZYAERockfish Bio
senolytics, IAAC-based therapies, mRNA-based therapies
clearingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-ZYAE
C-ZYAEC-ZYAEsenolytics, IAAC-based therapies, mRNA-based therapies
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ein weiteres spannendes Interview vom Rejuvenation Startup Summit von Forever Healthy. Diesmal spreche ich mit Ingo Lämmermann, CEO des Startups Rockfish Bio, über die Möglichkeit seneszente Zellen mithilfe von Arachidonsäure zu bekämpfen. 🔬 Highlights: - Ingo Lämmermann und sein Team haben festgestellt, dass seneszente Zellen, die alternden und nicht mehr teilungsfähigen Zellen, einen veränderten Lipidstoffwechsel aufweisen. Insbesondere der erhöhte Arachidonsäure-Stoffwechselweg wurde als Merkmal dieser Zellen identifiziert. - Die Methode, die Lämmermann entwickelt hat, zielt darauf ab, den Abbau der Arachidonsäure kurzfristig zu hemmen, wodurch die Konzentration proinflammatorischer und pro-fibrotischer Produkte reduziert wird. Dies führt dazu, dass die seneszenten Zellen sich selbst vergiften und sterben. - In präklinischen Studien konnten signifikante Verbesserungen bei der Muskelkraft und der allgemeinen Gesundheit von natürlich gealterten Mäusen beobachtet werden. Nach einer
One Health sollte als die Einheit von menschlicher und tierischer Gesundheit sowie deren Abhängigkeiten und Interaktionen verstanden werden. Welchen Einfluss hat unsere Ernährung auf die Umwelt? Welcher Zusammenhang besteht zwischen der Gesundheit von Menschen und Tieren? Was muss in der Tierhaltung passieren, um Gesundheit zu gewährleisten? Die BOKU hat einen starken Fokus auf Biotechnologie: vom Gen zum Produkt. Außerdem im Fokus: Impfstoffentwicklung und -produktion und neue proteinbasierte Biopharmazeutika. Es geht um effizientere und leistbare Herstellung von Medikamenten und Therapien, die allen zugänglich sind, sowie um die Entwicklung von neuartigen therapeutischen Ansätzen und Medikationen. Keynote: Eckart von Hirschhausen Arzt, Wissenschaftsjournalist und Gründer der Stiftung "Gesunde Erde-Gesunde Menschen" "Klimakrise – größte Gesundheitsgefahr oder größte Chance?" anschließend Podiumsdiskussion mit Reingard Grabherr Institut für Molekulare Biotechnologie (BOKU) Sara H
#iot #digitalization #iotmonetization #freeeway | Freeeway AG LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy … toxicological side effects, secured funding and received the S&B Foundation Award. red-stars.com data AG #Digitalization #LifeSciences #IoTMonetization #SubscriptionEconomy #IoTConnectivityManagement #IOTCMP #CloudTransformation #Biotech #DrugDevelopment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in More Relevant Posts Medvolt 1,697 followers 8mo Report this post 𝐈𝐧 𝐭𝐡𝐞 𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭! | 𝐌𝐞𝐝𝐯𝐨𝐥𝐭 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐍𝐀𝐒�
Thomas Streimelweger — Grokipedia Search ⌘K Suggest Edit Sign in Sign in Early Life and Education Childhood and Family Background Academic Career Professional Career Founding and Leadership of red-stars.com data AG Involvement with S&T AG Other Ventures Investments and Advisory Roles Other Ventures and Contributions Engagement in Life Sciences Board Memberships and Non-Executive Roles Personal Life Residence and Family Interests and Philanthropy Awards and Honors Professional Recognitions Decorations Received References Fact-checked by Grok 5 months ago Thomas Streimelweger Ara Eve Leo Sal … research holding GmbH (2004–2008), which operated a statistical arbitrage hedge fund liquidated before the 2008 financial crisis. [1] He has served on numerous executive and supervisory boards, including as deputy chair of the supervisory board and non-executive board member of HeartBeat.bio AG, a life sciences firm focused on gene therapies and organoid technologies, as well as Chairman of boards at a:head bio AG and MAVOCO AG. [3] [2] His expertise spans IPO processes, inte … s.com data & research holding GmbH, launching a statistical arbitrage hedge fund in the Cayman Islands that operated from July 2007 to July 2008 and was liquidated before the 2008 financial crisis. [6] [1] Investments and Advisory Roles Thomas Streimelweger has held a prominent advisory role at MAVOCO AG, a Vienna-based provider of IoT connectivity management software, where he served as chairman of the board from 2018 to 2024. In this capacity, he contributed to strategi … from the company he founded in 1987, S&T AG won the European IT Excellence Award in the category for providers of vertical solution markets. The award recognized the company's development of an advanced E-Government portal for Serbia, which enhanced public access to over 50 online services—including electronic forms, digital signatures, and tax payments—improving administrative efficiency in the region. This accolade, presented in London against competitors from 23 Europ … g candidates for healthy aging. The company received the Science & Business Award 2025 from the Rudolf Sallinger Fund, honoring early-stage commercialization of scientific breakthroughs in targeting senescent cells to combat age-related diseases without affecting healthy tissue. This €10,000 prize validated the venture's potential in bridging
ÖGMBT - Khassidov Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual Meeti … news: Read the latest… in Allgemeine News Life Sciences Awards Austria - Deadline: May 27 Life Sciences Awards Austria The Annual… in Mitgliedsnews 18th ÖGMBT Annual Meeting 2026 | FEMS Regional COLLAB & FEBS3+ Meeting, Vienna Registrations Now Open! 18th ÖGMBT Annual… in Mitgliedsnews Zur Newsübersicht Jobbörse University Assistant Prae-Doc (all genders) TU Vienna, Vienna Research position in Microbial polymer production acib GmbH … ad more... Rockfish Bio AG Wednesday, 27 March 2024 12:05 Read more... Call for Application: Peers4Careers 2024 Tuesday, 30 January 2024 02:10 Peers4Careers is back! Applications will be accepted through March 3, 2024 exclusively via a brief video statement. Please email your 2-minute video to This email address is being protected from spambots. You need JavaScript enabled to view it. . Setting goals is easy, but reaching them is not always straightforward. That's where P … e and how you will benefit from it. Register here . For more information on the application process, please check out our website or get connected with one of our program managers in charge, This email address is being protected from spambots. You need JavaScript enabled to view it. and This email address is being protected from spambots. You need JavaScript enabled to view it. ?subject=Peers4Careers"> Simone Fürst . Read more... The FEMSmicro Monthly: January Monday, 05 … ebinar in the pipeline, and several updates from the FEMS journals, awards, and grant programmes. All the best, The FEMS Team FEMS Journals Now, all but one of the FEMS Journals have transitioned to Open Access and all papers in those journal archives are free-to-read! Unlock your research's potential and join us
#digitalization #lifesciences #iotmonetization #subscriptioneconomy #iotconnectivitymanagement #iotcmp #cloudtransformation #biotech #drugdevelopment | Georg Schoder, CFA LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Ag … toxicological side effects, secured funding and received the S&B Foundation Award. red-stars.com data AG #Digitalization #LifeSciences #IoTMonetization #SubscriptionEconomy #IoTConnectivityManagement #IOTCMP #CloudTransformation #Biotech #DrugDevelopment 75 5 Comments Like Comment Share Copy LinkedIn Facebook X Mario Schwarz-Maurer 11mo Report this comment Congrats 👏 Georg Schoder, CFA Thomas Streimelweger m Like Reply 1 Reaction Davor Šakić 11mo Report this comment
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
%PDF-1.7 %���� 1 0 obj >/Metadata 718 0 R/ViewerPreferences 719 0 R>> endobj 2 0 obj > endobj 3 0 obj >/XObject >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 720 540] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x���_k�0�w���= ��N,J�i������P�` �34�������ܮi�� ���t���ˮ��,�a���_��� �sԠ9��]�{�Π��r���� A���P���}�=X�Ua��ϧ���9����C&I$�Lp( !;�g�sf���W���0n�YUD0oa�e�3k^��6k*6�d��Y����'f�� �R��5�� %��ݩe���)3ŵd� ���WCE�� ,}�>��U�g�אָ�&��g�[���q �K��,G�g�'����y]4y�sʼn@a���bb��Sɑ�튲 E�6=�}r|���iz�g� > endobj 6 0 obj > stream x��݇[� 7
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Global Venturing Global Venturing | Past Events Where Global Innovation and Capital Meet Home --> Register Login Go Corporate University Impact Full Site Corporate University Impact Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More --> News People Analysis Dea
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Data Privacy – Rockfish Bio Contact Imprint Data Privacy Contact Imprint Data Privacy Data Privacy General and Legal Basis Thank you for your interest in the Rockfish Bio AG website. The issue of data protection and confidentiality is a topic we take very seriously and we follow the applicable national and European data protection regulations. The EU General Data Protection Regulation, the Data Protection Act 2000 and the Data Protection Amendment Act 2018 stipulate the right to protection of personal data. We process your data exclusively on the basis of legal regulations (GDPR, DSG 201
%PDF-1.7 %������� 1 0 obj > endobj 2 0 obj > endobj 3 0 obj > endobj 4 0 obj > endobj 13 0 obj > endobj 14 0 obj > endobj 15 0 obj > endobj 16 0 obj >stream "#$%&'()*+,-./0123456789:; > endobj 18 0 obj >stream /CIDInit /ProcSet findresource begin 12 dict begin begincmap /CIDSystemInfo 3 dict dup begin /Registry (Adobe) def /Ordering (Identity) def /Supplement 0 def end def /CMapName /Aspose-Identity-UCS def /CMapType 2 def /WMode 0 def 1 begincodespacerange endcodespacerange 95 beginbfrange endbfrange endcmap CMapName currentdict /CMap defineresource pop end end endstream
ÖGMBT - Life Sciences Career Fair 2024 Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meet … Scientific Computing, positions in academic and business administration (e.g.; Grant management, Faculty recruiting, Communications, etc.), and IT. Jobs at ISTA: ista.ac.at/en/jobs Number of Staff: 1000 Locations: Klosterneuburg, Austria Homepage: https://ista.ac.at/en/home/ Positions offered: short-term internship; PhD position; entry-level position; position with first experience; specialised position Candidates wanted: Students with a Bachelor’s or Master’s de
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Rockfish Bio wins prestigious Science and Business Award 2025 Skip to main content Deutsch Menu Menu Deutsch close Search Search About us News Events Facts & Figures Strategy and Vision Organisation Campus and University Life Contact points for victims of discrimination and sexual harassment University Library Young Scientist Association (YSA) Wissenschafterinnennetzwerk für Medizin Alumni Club History Historical collections - Josephinum Research Research at the MedUni Vienna Areas of Research Eric Kandel Institute - Center for Precision Medicine Artificial Intelligence und Machine Learning R … icine Master’s Programme PhD & Doctoral Programs Postgraduate Distance Learning Application & Admission Student Exchange Nostrifizierung Advisory service and contacts Campus and University Life Health & Clinics Universitätsklinikum AKH Wien Departments / AKH Wien (University Hospital Vienna) Institutes and Centers Outpatient departments & services Medical Services Good health and well-being Mediziner:innen kontra Rauchen MedUni Wien-Tipp: Richtiges Händewaschen #expertcheck C … ni Vienna External lecturers Rockfish Bio wins prestigious Science and Business Award 2025 S&B Award: Spin-off from MedUni Vienna/BOKU receives funding from the Rudolf Sallinger Fund Home About us News 2025 News in June 2025 Rockfish Bio wins prestigious Science and Business Award 2025 All News – University , Medicine & Science (Vienna, 03 June 2025) Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candida … Bio's compounds eliminate them without harming healthy cells. With the S&B Award, the Rudolf Sallinger Fund honors early-stage commercialization ideas based on scientific achievement. Preclinical studies have shown remarkable effects, including extension of both lifespan and healthspan and restoration of neuromuscular function, supporting the therapeutic potential of these compounds in promoting healthy aging and treating age-related conditions. “We are honored to receiv … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Ingo Lämmermann, CSO/COO of Rockfish Bio. The award-winning team includes Ingo Lämmermann and Johannes Grillari from BOKU U
Imprint – Rockfish Bio Contact Imprint Data Privacy Contact Imprint Data Privacy Imprint Disclaimer Responsible for the content and the acquisition, processing and utilization of person-specific data is Rockfish Bio AG. Rockfish Bio AG can be reached by Post: Rockfish Bio AG, Leberstraße 20, 1110 Vienna, Austria E-mail: [email protected] Represented by the managing director: Klaus Weinberger European Commission consumer platform for Online Dispute Resolution (ODR): https://ec.europa.eu/consumers/odr/ We are neither willing nor obliged to participate in dispute resolution proceedings … kfish Bio. Except for the above restricted authorization, Rockfish Bio does not grant you any license or copyright. This website may contain protected trademarks, patents, information on owners, technologies, products, processes or other property rights held by Rockfish Bio and/or third parties or may refer thereto. No license or other right is granted with respect to such protected trademarks, patents, information on owners, technologies, products, processes or other propert
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Ingo Lämmermann at Rockfish Bio AG - Research Interests, Publications & Academic Profile | ApplyKite Solution Resources Log in Try for free open navigation menu Home Professors Professor detail Ingo Lämmermann Chief Scientific Officer Is this your profile? University Name Austria This profile is automatically generated from trusted academic sources. Google Scholar . ORCID . LinkedIn How do I reach out? Sign in for free to see their profile details and contact information. Google-color Created with Sketch. View contact info Continue in dashboard Meet Kite AI Draft a cold email to contact a … tact Privacy Policy Terms of Service Affiliation Review us on Trustpilot © 2026 Apply kite. All rights reserved. +(44) 2034885486 60 Tottenham Court Road, Suite 6422a, Fitzrovia, London, United Kingdom, W1T 2EW
“Rockfish” wins Research to Market Award – Austrian Cluster for Tissue Regeneration Skip to content HOME THE CLUSTER About the Cluster Members Associate Members Media Career Reference Book Series Publications RESEARCH Neuro Regeneration Soft Tissue & Skin Regeneration Bone & Ligament Regeneration Cartilage & Tendon Regeneration Aging Research Technology Platforms NEWS CONTACT Navigation Menu Navigation Menu HOME THE CLUSTER About the Cluster Members Associate Members Media Career Reference Book Series Publications RESEARCH Neuro Regeneration Soft Tissue & … echnology Platforms NEWS CONTACT “Rockfish” wins Research to Market Award by TissueRegAustria September 15, 2025 September 15, 2025 We are delighted to announce that Rockfish Bio, an associated member of the Austrian Cluster for Tissue Regeneration, has won the BOKU “Start-up” Award for research in the field of Healthy Aging. Rockfish convinced the jury with novel senolytic drug candidates that selectively eliminate aging, dysfunctional cells (senescent cells) wit … diabetes, cardiovascular disease, and chronic kidney disease. The BOKU Start-up Award recognizes projects that have successfully transformed innovative research ideas into business ventures. Assoc. Prof. Johannes Grillari, professor at BOKU, director of the Ludwig Boltzmann Institute for Traumatology and co-founder of Rockfish, expressed his delight at the recognition: “Innovative research in Austria requires stable framework conditions that enable start-ups to make the leap … : Developing effective therapies against age-related diseases Awards: Sallinger Fund Award 2025, Top 3 in the “Spin-offs” category at the Phoenix Award 2025 Awarded: September 11, 2025 – BOKU Start-up Award ceremony Search Search Recent Posts Project pitches showcase the next generation of biomaterials researchers at TU Vienna State prize honors animal-free osteoarthritis research Vet4Reg Congress 2026 – Registration open! From Palma to Vienna: Shrunkhala Mahadik
Rockfish Bio Wins Prestigious S&B Business Award 2025 zum Inhalt Main Search Choose the search context Search Search for: Start search Staff and BOKUweb content Staff only Quicklinks Links Groupwise Webaccess Studentmailing BOKUbox Filr Netstorage BOKUdrive Change password FM Helpdesk Document Collection Literature search BOKU:LITsearch Abstracts ArgeData Onlineportals BOKUportal BOKUonline BOKUlearn (Moodle) FIS New Mitteilungsblatt Jobs Welcome Center Diversity, Equity and Inclusion Contact University Management Service Units Sites BOKU Navi Special Organs and Institutions Staff Alumni B … s BOKU Inside BOKU in den Medien Rockfish Bio Wins Prestigious S&B Business Award 2025 BOKU-Start This page is available under these URLs: https://boku.ac.at/en/news/newsitem/84788 The BOKU/MUW spin-off Rockfish Bio AG was honored in May 2025 with the Science & Business Award (S&B Award) of the Rudolf Sallinger Fund, receiving the main prize of €20,000. vergrößern The S&B Award supports innovative commercialization ideas in early development stages that are ba … ifespan and healthspan, as well as restoration of neuromuscular function. “This award affirms our mission to develop effective therapies against age-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. The founding team consists of Dr. Ingo Lämmermann and Assoc. Prof. Dr. Johannes Grillari from the Institute of Molecular Biotechnology at BOKU Vienna and the Ludwig Boltzmann Institute for Traumatology, together with Otto Kanzler and Thomas Streimelweger o
Global Venturing Global Venturing | Past Events Where Global Innovation and Capital Meet Home --> Register Login Go Corporate University Impact Full Site Corporate University Impact Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More --> News People Analysis Dea … ound For: "Cheap fc 26 coins Buyfc26coins.com has the perfect answer : How do I apply for FC 26 Coins legal assistance?.Ky2m" No results found. --> --> About us GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and
Notes from the Rejuvenation Startup Summit in Berlin, May 2024 – Fight Aging! Home FAQ Fund Research Services Investing Therapies Newsletter Archives Press Room Resources About Fight Aging! Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is progress in medicine: building new classes of therapy to repair and reverse the known root causes of aging. The sooner these treatments arrive, the more lives will be saved. Find out how to help » May 13th, 2024 No … ficial effects throughout the body. The company is planning a series A round to fund the path to a first clinical trial in the rare genetic condition of homozygous familial hypercholesterolemia in 2026, with a potential fast track approval leading to off-label use for severe atherosclerosis in the general population. Brian Kennedy of the National University of Singapore (NUS) opened his presentation with a complaint about the lack of preventitive treatment taking place in the … engineer very selective expression of transgenes in specific tissues. The first application is to upregulate follistatin in to produce muscle growth. The team has demonstrated this outcome in mice, including in very old mice. The second application is to destroy unwanted fat cells, and the technology can selectively target specific fat pads via promoters that are only active in those tissues. They can also change the fusogenic LNP to more selectively target fat cells specific … ty Center Europe, Petr Sramek of the Healthy Longevity Clinic and LongevityTech.fund and Elisabeth Roider of the AYUN Health & Longevity Center presented on their respective longevity clinics. The most interesting of these projects, the one that isn't just a provision of boutique medical services, is the Healthy Longevity Clinic. This group are trying something new, a fusion of investing in companies, giving those companies a path to clinical trials outside the US, and cl … Living Longer Read the Fight Aging! FAQ Sign up for the Fight Aging! Newsletter Fund Meaningful Aging Research Services Longevity Industry Consulting How to Start a Longevity Biotech Company The Root Causes of Aging Aging is Caused by Damage Accumulating Cross-Links Buildup of Amyloid Between Cells The Failing Adaptive Immune System The Failing I
Global Venturing Global Venturing | Past Events Where Global Innovation and Capital Meet Home --> Register Login Go Corporate University Impact Full Site Corporate University Impact Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More --> News People Analysis Dea
red-stars.com — mission-critical B2B software & life-sciences companies
Crosshair Therapeutics - Products, Competitors, Financials, Employees, Headquarters Locations Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors &am … rs (and a backer of several companies on this list) in the space: Longevitytech.fund. The company was co-founded by the fund’s managing partner Petr Sramek to give customers access to cutting-edge therapies and diagnostics faster than would be possible through the traditional health systems. It offers several distinct programmes to customers, focused on brain health, heart health, cellular regeneration, regenerative aesthetics (essentially, getting rid of visual signs of age) … edite human ageing studies and evaluate anti-ageing therapeutics. Longevitytech.fund lists Cosmica in its portfolio, but it’s unclear how much the company — a spinout from the Buck Institute — has raised. Crosshair Therapeutics Crosshair Therapeutics has developed a technology platform, dubbed D-Chain, that it hopes will enable precision targeting for immunotherapies. It uses computational modelling to design its therapeutics and an engineered adeno-associated virus for preci … ers and lets them vote on which scientist-vetted longevity research projects to fund. Profits are funnelled back into VitaDAO’s coffers to support future projects. To date, it’s funded 22 projects and invested more than $4.2m. Matrix Bio is the first company coming out of VitaDAO and it is commercialising research by Vera Gorbunova, the co-chair of the University of Rochester’s Aging Research Center. The company is looking to develop high molecular weight hyaluronic acid (HMW … ple. The company has raised an undisclosed amount from NFX, a pre-seed and seed fund that also runs a private community of founders and runs programmes like executive coaching for its portfolio companies. Rockfish Bio Rockfish Bio is working on senolytic compounds — small molecules that could induce the death of cells that have stopped dividing (
Global Venturing Global Venturing | Past Events Where Global Innovation and Capital Meet Home --> Register Login Go Corporate University Impact Full Site Corporate University Impact Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More --> News People Analysis Dea
ÖGMBT - Putz Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual Meeting 20 … news: Read the latest… in Allgemeine News Life Sciences Awards Austria - Deadline: May 27 Life Sciences Awards Austria The Annual… in Mitgliedsnews 18th ÖGMBT Annual Meeting 2026 | FEMS Regional COLLAB & FEBS3+ Meeting, Vienna Registrations Now Open! 18th ÖGMBT Annual… in Mitgliedsnews Zur Newsübersicht Jobbörse University Assistant Prae-Doc (all genders) TU Vienna, Vienna Research position in Microbial polymer production acib GmbH … 9;26. Aiming to gather as many young talents as possible , we have extended the application deadline to June 10! Seize the opportunity! There are great prizes to be won: Life Science Research Awards Austria supported by the Federal Ministry for Economy, Energy and Tourism (BMWET) Basic Science (1 Prize of € 3.000) Applied Research (1 Prize of € 3.000) Excellence & Societal Impact (1 Prize of € 3.000) Life Science PhD Awards Austria supported by Polymun Scie … stria supported by Polymun Scientific and Boehringer Ingelheim Basic Science (1 Prize of € 1.500) Applied Research (1 Prize of € 1.500) Moreover, the awardees will have the unique opportunity to present their prize-winning work at the FEMS Regional COLLAB and FEBS3+ Meeting – 18th ÖGMBT Annual Meeting , in front of the who's who of the Austrian and international Life Sciences community. Details can be found at: https://oegmbt.at/awards Read mor … at: https://oegmbt.at/awards Read more... Life Sciences Awards Austria - Deadline May 27 Monday, 08 June 2026 02:43 Apply now! Deadline 27 May 2026 Life Sciences R esearch Award s Austria Each year, the ÖGMBT awards prizes to young researchers who have published outstanding scientific research papers in the field of life scienc
%PDF-1.7 %���� 2061 0 obj >stream h��[�\�~�� UI� ,��a��8���`��w� l/l�>_I���L�z���t��H:��W7�J�H���'?E�4LT�fd�T� i�_�L�xd���#2�O��u�)m ┒V�2e�Z��\�fPr^k;�t9h-��B��_�Iֺ��tm��JE M����L�Kb���F&��;�g &��� E���8I����D%'�u���$Bg4�0�d�B�)�ȓ�91� �pR�X@O� jv�:�4sĀ��P�''0O@��0��L�љx|� ��>%b,}J�X�Y�#P�r�ypA2�����]Y���)� FB RRE�"I�Ȁ�D���~*(G���cT�09*�����CۢC*1Ne��U���*h�G���T6�JI8 �&�>�_R� �O !�cUHXi��$�d ���Kf��" -�J�D� q����*�A��V�a�h�TD�f�*�)���ڑ��J�T"��� "�7k��1n��t�\0˂q��z�� 8�^��w���ː}�@�b�l&�P �R�v�U� @��U�����I%Y�U�C�\+��L��,�F15a��|T�BGD … ��;��Z:m���_^����f��~��m Nly�ت�,�o�{vͿ}��n��˭���ƙ?Y��?\9���~w��ﮚ���3��G���RFp��3���ϧțQ8 �l�� �q*,Z��X� J��wzA}�0����Z>q��9��-�� ��z��O*�ܣ��b��]�#�6�O�ge���&�S ����>q�g��=9zb� /�,̞X^" �4�O ܩ[��������� �X��wJ��w-��1�}�Ҁ��� � |vZ� �KG�����'lʔ�]��8ɖ �?G�>�`��� }���������j�'��f�^m�i�|*2K��87��s�}���Y7�rO}��(e�f��O#�4�GE�Iۍ }�g�j��>1�4�Z���PY�����5@�~��誢O�d� �T[��/�t�g���Z1�Jx��'��}2�O��j�m̩� ��+ҍ|�ѧ�v�SЧ h&��}�d J�'�IM�ur�d� !� ��4>MBB�� … ��[,ڼ?�>�?��E���4��Ӛ�G`���v�T�+^�\��!c[��T��,�K�xl7 \��l �ݭ�Y�+�-��-��RfP� ˗�P��WBң�ٞW�;�{k��b�9m��ջr��S��ib�ϓ���X���!=M��ϳk� w�_��ٵor��o�_����g P���,�V�+�u�sqN @w�s��%s��E�-�}���v��= ��` �np�:}��d ����ԧf���3�g>�Y�}v���KP�kS� ��3S��ZJ}����V��������ݫO x�Vh�V ���߃{� �{���� z��=�� [j̚wg'���F;�KM��I.�\ڍ[!a���� ����������Eyˏ+ھ���+:~r������~��ܡ�8��~\���C�y��������/GR���/{��~�7��?���՞^~)>�Zb�]|�#j�w�Z�ڤL�)W:�k=��^��5u�S�Ѧ\���k�ʕf���F�v�3uC�١N�� … �x�Sc����?�,�� �X6٥A ����'/)w���O4�Г�'>��Y'���gL�KnY�ԥ��gl���=�'�/q��'��6��RfP�TCg��?� ��Rz� �p�i�Oܝ��YRH�,J�O%}�S�͛�':�yc��O�=�I��p�y T�qOR�du�3Z����;y��GQ���i��D���9������ ?���K��$��I���1O|x0���� J���`�A)/�>�~ ��� }~�^v�.�ݝ�� �� ~���R`�Ļgr���>�Mϯ���=Yޖ�%X{[ޒ�lJ�Q�� ��hu}���T��&Q^��|6��^e= ����ꆩ�@��n��9/��'�n�%�x2%p�'j�* ~����*�\���&�'�k��[RV��ܿ��d�mS��9Yߒ/������xtC��6w�n�Y�"S�2S�j�q��|�%y�m����s��=��s_|K�-�=0 ��P�C%��q�Oz�aO���;oQ� … 3S� �=�->�����ͨ�Ϭ��ddj �j��yL@a^mq�����F>�yO���R���Bf���F`Ո뙒z,�iP� ��rFp��\��˖Ad\�B�U�xJ���1*���JUr�Z&l��$ ������d@!�S(�b�\\-���bNUA-=��8�^�� ��@V� ��Ii��f��VM� M�g�yզ���Uլ͊�Z[T��v$�JO�NT�R#�Q��4!���'x�A��_���߶K߾�~�.}�*} g��(d�r8��Z&�����4��0=/'%�� hړ��G)���R $e>J�H|Z�,�,#�27�U��+ϗ�K$�ԦJ��NU�Q奅��|iz��3֣��;�h�o�FFg�
Featuring Future Conference::Public Relations::Staff units::Rectorate::BOKU zum Inhalt Main Search Choose the search context Search Search for: Start search Staff and BOKUweb content Staff only Quicklinks Links Groupwise Webaccess Studentmailing BOKUbox Filr Netstorage BOKUdrive Change password FM Helpdesk Document Collection Literature search BOKU:LITsearch Abstracts ArgeData Onlineportals BOKUportal BOKUonline BOKUlearn (Moodle) FIS New Mitteilungsblatt Jobs Welcome Center Diversity, Equity and Inclusion Contact University Management Service Units Sites BOKU Navi Special Organs and Instituti
ÖGMBT - Companies Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual Meeti … e-newsletter with updates on the field, member activities, jobs, select events, grant deadlines, seminars etc. Special discounts on online banner ads in Job board Further education board ÖGMBT e-newsletter (sent to > 1.300 members & multipliers) Free subscription to Chemiereport magazine, published 8x/year, 9.000 subscribers (delivered only to addresses in Austria) Possibility to suggest hot topics for the ÖGMBT column in the Chemiereport magazine SMEs up to
SynBioBeta Entrepreneurs Remain Dedicated to Vision | Liz Specht, Ph.D. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agr
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Longevity @Berlin: Europe gains traction The LongX Blog Subscribe Sign in Longevity @Berlin: Europe gains traction Recap of the Longevity Week & Rejuvenation Start-up Summit LongX - Longevity Xplorer and Denisa Lepadatu May 16, 2024 1 Share Why Berlin? For the past two decades, Berlin emerged as a hotbed for start-ups (particularly in tech), thriving in an environment of constant change and a vibrant cultural scene. Then, think of the Germany-based Forever Healthy Foundation (holding the Rejuvenation Start-up Summit) and founders (such as Emil Kendziorra of Tomorrow Biostasis) who were at … m digital health apps tracking your aging and fertility to venture capital (VC) fund intros, Vitalism Meet-up, for the hardcore supporters of the movement, Special dinners, And the well-known Rejuvenation Start-up Summit (RSS). Who gathered for such events? The expected crew of longevity scientists, entrepreneurs, and investors was complemented by a large number of medical doctors, performance coaches, biohackers, and influencers. This came as no surprise, with quite a few ev
Rejuvenation Startup Summit 2024 - Highlights | Lifespan Research Institute Back to lifespan Home Login Return to Lifespan Homepage Donate Login News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financial Blockchain Investing Advocacy Policy Public Outreach LRI News Interviews Op-Ed Editorial Editor’s Pick Rejuvenation Roundup Press Releases News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfu … th with a keynote talk by Mehmood Khan, CEO of Hevolution, the Saudi non-profit fund that has been pouring considerable money into longevity research. Khan brings to the longevity field decades of experience managing giant companies such as PepsiCo, and his presentation skills are always on full display at conferences. Khan is also an MD with a background in endocrinology. Khan started with the overview of the challenges with which “population greying” is presenting the world
%PDF-1.3 %���� 79 0 obj > endobj xref 79 48 0000000016 00000 n 0000001863 00000 n 0000002125 00000 n 0000002495 00000 n 0000002628 00000 n 0000002759 00000 n 0000002891 00000 n 0000003026 00000 n 0000003156 00000 n 0000003809 00000 n 0000003874 00000 n 0000004333 00000 n 0000004358 00000 n 0000004383 00000 n 0000004967 00000 n 0000005463 00000 n 0000005488 00000 n 0000006087 00000 n 0000006112 00000 n 0000006137 00000 n 0000007476 00000 n 0000008627 00000 n 0000009833 00000 n 0000011025 00000 n 0000012189 00000 n 0000013574 00000 n 0000014783 00000 n 0000015724 00000 n 0000022592 00000 n 00000 … s������p�M�����H�F6�$��h�Ml��18�j,~�� ��z�~M�n�j�^��\�[���W�N� �{a�U=Q�C珜ϋs�rFp��5':">DLJ� �X$l=� ێ�TA�"� �bp�$yC�>��9���� 9r�й'4�gs�s \;�̓0G� ��:� i�z�"8;w����I�R �����o֥����3���N��7{y�Ɇ� Kc �k+�Ѐs�_��b�L �� L � ���b`N�W�1݂���h�z��z4kD�R1���{u�ܫQ���j� ������L �B�Ƚ������6Ɂ�s�(�0egBj9g � �R2\c��oHS�{��N M�h�J�t����Ɗ�� �W�e�������=9�r����5�J�`����� ���}2�������(������:�� F�\?|�ѳ �OΤ��۹h�u��1b�A���+�}����\w%� ��K�����L}4I� �H�3�C�U]�߸O�n … -11db-a4b0-a852c3fbee13 adobe:docid:indd:43546d76-7aac-11d8-b743-c3004be8dc4a 1 application/pdf 01 Witherell WEB MFR 67(1).indd endstream endobj 78 0 obj > endobj xref 0 79 0000000000 65535 f 0000045281 00000 n 0000045597 00000 n 0000049457 00000 n 0000309150 00000 n 0000309462 00000 n 0000317945 00000 n 0000318245 00000 n 0000324713 00000 n 0000325001 00000 n 0000328678 00000 n 0000328968 00000 n 0000339506 00000 n 0000339825 00000 n 0000343644 00000 n 0000755374 00000 n 000
%PDF-1.2 %���� 39 0 obj > endobj xref 39 34 0000000016 00000 n 0000001027 00000 n 0000001426 00000 n 0000001633 00000 n 0000001811 00000 n 0000002669 00000 n 0000002883 00000 n 0000003095 00000 n 0000003295 00000 n 0000004077 00000 n 0000004871 00000 n 0000005051 00000 n 0000005072 00000 n 0000005782 00000 n 0000005803 00000 n 0000006489 00000 n 0000006510 00000 n 0000007212 00000 n 0000007233 00000 n 0000007971 00000 n 0000008186 00000 n 0000008975 00000 n 0000009182 00000 n 0000010022 00000 n 0000010043 00000 n 0000010677 00000 n 0000010698 00000 n 0000011323 00000 n 0000011344 00000 n 00000
Great interest in our senolytic drug development program here in the bay area! | Johannes Grillari LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree t
%PDF-1.7 %���� 160 0 obj > stream H���yTSw�oɞ����c [���5la� QIBH�ADED���2�mtFOE�.�c��}���0��8��8G�Ng��� ��9�w���߽����'����0 �֠�J��b� 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�j@�&�A)/��g�>'K���t�;\�� ӥ$պF�ZUn��� �(4T�%)뫔�0C&�����Z��i���8��bx��E���B �;�����P���ӓ̹�A� om?�W= �x������-�����[���0� ���}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą? �_ ��yxg)˔z���çL�U���*�u�Sk�Se�O4?�c����.�� ��R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9�=�-� t
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.5 %���� 2230 0 obj > endobj 2265 0 obj ]>>stream x�%�+Aq ���8���Z4E�̘ Ql�� M4�)�� B4$ɦ�0EU$��l�;婏���)`�cbO��܃�\�|� �@o.J�� ��)]��&u���� �j�5�(�i�6J���,�E���-���P��[c��hb���FLD'fb!Vb#v� N�"n�!^�#~b� � ��� )9U endstream endobj 2232 0 obj >stream x�c```a``8������� ̀� l @Y +�F. �f ם1�^�5'�9E �>���y����>����%�0 �J�ʊ��j@���"5A���:� RD�WEE7�" O��n^��ϳ*��|>�ȸ2�l����A���h���2Ԫ�9?p�\��Y�3敾,�|�U;s^q���O�Uv�k^�W�ye/�U��_�l^I&S��Ο@s��|�W�=���\O��� U��9U�������s�U�Z4���UM@�2�I�ϋ�+��)t>/��9�a͊ȗjUa��ߑ��4� gou�� �W��u��*֥��6�?���g ��c�����0� … !�Km����� 2\�>��bH�L���4>�8�(V�4�G��o�� endstream endobj 2263 0 obj >stream application/pdf LISAvienna-Logo_cmyk 2012-06-26T15:59:52+02:00 2012-06-26T15:59:52+02:00 2011-08-29T17:28:48+02:00 Adobe Illustrator CS4 uuid:efc6fe35-272a-4b45-af67-af6b5f5dc394 xmp.did:02801174072068118DBBDBC07F7D50E6 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:f14bcffd-6789-4a71-9554-60facc9b4e55 xmp.did:0B9FED35200A11689FE8CB9EA85C5459 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf c … 9FE8CB9EA85C5459 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf converted from application/pdf to <unknown> saved xmp.iid:D27F11740720681191099C3B601C4548 2008-04-17T14:19:15+05:30 Adobe Illustrator CS4 / converted from application/pdf to <unknown> converted from application/pdf to <unknown> saved xmp.iid:F97F1174072068118D4ED246B3ADB1C6 2008-05-15T16:23:06-07:00 Adobe Illustrator CS4 / saved xmp.iid:FA7F1174072068118D4ED246B3ADB1C6 2008-05-15T17:10:45-07:0 … DDFD38D0CF24DD 2008-05-16T10:35:43-07:00 Adobe Illustrator CS4 / converted from application/pdf to <unknown> saved xmp.iid:F97F117407206811BDDDFD38D0CF24DD 2008-05-16T10:40:59-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to <unknown> saved xmp.iid:FA7F117407206811BDDDFD38D0CF24DD 2008-05-16T11:26:55-07:00 Adobe Illustrator CS4 / saved xmp.iid:FB7F117407206811BDDDFD38D0CF24DD 2008-05-16T11:29:01-07:00 Adobe Illustrator CS4 / saved … C1BF14D1759E83 2008-05-16T15:52:22-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator saved xmp.iid:FA7F117407206811B628E3BF27C8C41B 2008-05-22T13:28:01-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator saved xmp.iid:
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
STARD Zum Inhalt FFG Projektdatenbank Navigation ein-/ausschalten FFG Projektdatenbank Projekte (aktiv) Organisationen Breadcrumb Navigation Startseite Projekte STARD zurück STARD novel Senolytic Therapies for Age-Related Diseases Programm / Ausschreibung Life Sciences 24/26, Life Sciences 24/26, Life Sciences Ausschreibung 2024-26 Status abgeschlossen Projektstart 01.10.2024 Projektende 30.09.2025 Zeitraum 2024 - 2025 Projektlaufzeit 12 Monate Keywords senolytic; age-related disease; aging; cellular senescence; arachidonic acid Projektbeschreibung Rockfish Bio hat sich die Entwicklung von neu
%PDF-1.6 %���� 30968 0 obj > endobj 30992 0 obj >/Filter/FlateDecode/ID[ ]/Index[30968 428]/Info 30967 0 R/Length 142/Prev 14923738/Root 30969 0 R/Size 31396/Type/XRef/W[1 3 1]>>stream h�bbd```z �QDrp�Hf� &����� �H&��$����Yl�$��X�2�d���I�5`�L ��D��\�� ɿ�U L� � �T!�PѴQr����sG�a� MW��h�%�$���7s@��:� endstream endobj startxref 0 %%EOF 31395 0 obj >stream h��W}pSU?�&m�&�}iS���x/m�EWShu��$i�͘R ��N��?Р�Y��j��*��5�S�b���,>���S�X*�ϭ8� Lpa�Qֽ�%--����x�ɽ�s��{�7���M�� =\hzPB*��y����Ym��A��P�P�f�>�j%���>� �&� W� UaP��� ��IGc��ԵY�}��TW��C$�P� �euH[I�h2 �xV]Q��9�+� … �Fu��1��ϵ����������� ��̒'� Y#x���b� �zԟ��o� endstream endobj 46 0 obj >stream application/pdf IlluEN_01 2024-07-17T12:46:48+02:00 2024-07-17T12:46:48+02:00 2024-06-21T15:43:22+02:00 Adobe Illustrator 28.4 (Windows) uuid:9f802fd1-fcdd-498a-8eeb-441a61d00612 xmp.did:419ae810-bbad-314a-858f-9caac07249cf uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf 1 uuid:08bbe0c1-476b-4db5-9cbb-a9a975a477c0 xmp.did:dea5f44a-80e7-a642-a935-289244c266e8 uuid:5D20892493BFDB11914A8590D31508C8 1 … TQ��z)�J�;r��y�P� y [{;��LRןe�������t�o楰1 endstream endobj 99 0 obj >stream application/pdf IlluEN_02 2024-06-21T15:57:01+02:00 2024-06-21T15:57:01+02:00 2024-06-21T15:57:01+02:00 Adobe Illustrator 28.4 (Windows) uuid:2493c590-6475-41d5-84f1-3ba7c702c6d8 xmp.did:c693548e-3584-f849-bd3a-17e7b297eec3 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf 1 uuid:08bbe0c1-476b-4db5-9cbb-a9a975a477c0 xmp.did:dea5f44a-80e7-a642-a935-289244c266e8 uuid:5D20892493BFDB11914A8590D31508C8 1 … 呎���7��\�>]�g"k} �1����x��� xUx�W�*�D endstream endobj 116 0 obj >stream application/pdf IlluEN_02.1 2024-07-17T13:09:03+02:00 2024-07-17T13:09:03+02:00 2024-06-21T16:02:03+02:00 Adobe Illustrator 28.4 (Windows) uuid:fbcedfc4-8fc0-435b-a286-f0bfa212df41 xmp.did:3a213aad-7b7a-bf48-bc58-b0940f0610f4 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf 1 uuid:137c3fbd-08d2-47bd-9b87-629ff6cc07cf xmp.did:07e7acd1-0341-b04f-8be0-6457b2246f3d uuid:5D20892493BFDB11914A8590D31508C8 … Z��/%j/�B�����/�����t����]tciyGO�9/4��_��ٌ endstream endobj 124 0 obj >stream application/pdf FTB2024_Abb2-02 2024-06-20T10:26:36+02:00 2024-06-20T10:26:36+02:00 2024-06-20T10:26:36+02:00 Adobe Illustrator 28.5 (Windows) uuid:833e952c-e490-4bc5-9414-47e64b7e4427 xmp.did:de44a2cd-903f-c743-b5f2-3bde9f09b4e5 uuid:5D20892493BFDB11914A8590D31508C8
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
#rockfishbio #venturesummitwest #biotech #ckd #longevity #senolytics #agingresearch #lifesciences #venturecapital #siliconvalley #seriesa | Rockfish Bio LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedI … olorado via the Colorado-Israel Chamber of Commerce (COIL) , this is our second grant award in two years of activity! At a time when Israel is facing boycotts, misinformation, and efforts to push it out of global institutions, economic relationships become a form of strategic resilience. When a Colorado company partners with an Israeli company to improve agriculture, it is not abstract diplomacy but a tangible business connection that demonstrates Israel is not isolated and t … rael Chamber of Commerce was created to support. Moreover, this is the 2nd BIRD grant we have helped support as BIRD’s official partner for the state of Colorado since our founding in 2024. Colorado and Israel share strengths across agriculture, water, quantum, cybersecurity, energy, life sciences, aerospace, climate tech, and advanced technology. But, shared strengths only become economic value when the right people, companies, investors, institutions, and public partners ar … illed to announce that NeuroKaire has been awarded a $1 million BIRD Foundation grant to support a collaboration with Mindful Care, one of the fastest-growing and most innovative mental healthcare providers in the United States. Mindful Care was founded by Tamir Aldad, MD, MBA to address one of the biggest challenges in behavioral health: access. Through its unique model of urgent psychiatric care, therapy, medication management, and virtual services, Mindful Care has helped … yal Miller MBA, MA 1mo Report this post Identifai Genetics Wins BIRD Foundation Grant, Strengthening Its U.S.-Israel Collaboration Toward Commercialization of Advanced Prenatal Genetics. we are thankful to BIRD Foundation and big Kudos to our amazing team BIRD Foundation 5,052 followers 1mo We’re excited to announce the latest round of BIRD Found
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Geriatrie und Gerontologie | Senolytika: neue Wunderwaffe gegen altersassoziierte Erkrankungen? | springermedizin.at Geriatrie und Gerontologie | Senolytika: neue Wunderwaffe gegen altersassoziierte Erkrankungen? | springermedizin.at Zum Inhalt Menü Hauptrubriken Unsere Autor:innen und Expert:innen Zeitschriften Zeitungen Podcast Gesundheitspolitik Praxis Allerlei Jobs Fachgebiete Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopäd
Wie man mit 80 den Körper eines 30-Jährigen haben kann Zum Hauptinhalt der Seite End Google Tag Manager (noscript) --> Toggle menu News-Ticker Channels Channels Zurück Zur Channels Übersichtsseite Channels Produkte Science Netzpolitik Digital Life Games Apps Meinung Start-Ups B2B PR Künstliche Intelligenz Events Meistgelesen Science Mars-Rover könnte Spuren von antikem Leben am Mars gefunden haben Science Microsofts Quanten-Durchbruch könnte Programmier-Fehler gewesen sein Digital Life Minimalistischer E-Pick-up kann jetzt für 25.000 Dollar bestellt werden Militärtechnik Steuern ohne Ruder: … tspreis Innovation TECHNO Wissenschaft der Zukunft Zukunft gestalten futurezone award fuzo Features frag die futurezone Klimafreitag So funktioniert's futurezone Tests Community Gewinnspiele Events Aktionen futurezone.at ist ein Medium der k-digital Medien GmbH Allgemeine Nutzungsbedingungen Datenschutzrichtlinie Impressum/Offenlegung Werben auf futurezone.at Cookie Einstellungen Meldung nicht konformer politischer Anzeigen
#rockfishbio #senoyltics #healthspan | Rockfish Bio LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , … ers Oxford Science Enterprises and the University of Oxford . The proceeds will fund clinical development of RQB01, their lead programme targeting broad, durable protection against seasonal influenza for immunocompromised and high-risk patients. But the numbers don't tell the full story… RQ Biotechnology was born in 2021 and consisted of a small group of founding scientists (backed by LifeArc Ventures) looking for an antibody that would help protect people who are immunocompr
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Rockfish Bio partners with Eurofins Discovery! The partnership with the world-class CRO offers us an integrated drug discovery solution by combining chemistry, biology, ADME and pharmacology… | Rockfish Bio LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time
Rockfish Bio wins prestigious Science and Business Award 2025 Skip to main content Deutsch Menu Menu Deutsch close About us News Events Facts & Figures Strategy and Vision Organisation Campus and University Life Contact points for victims of discrimination and sexual harassment University Library Young Scientist Association (YSA) Wissenschafterinnennetzwerk für Medizin Alumni Club History Historical collections - Josephinum Research Research at the MedUni Vienna Areas of Research Eric Kandel Institute - Center for Precision Medicine Artificial Intelligence und Machine Learning Research Projec … erstudium Psychotherapie PhD & Doctoral Programs Postgraduate Distance Learning Application & Admission Student Exchange Nostrifizierung Advisory service and contacts Campus and University Life Health & Clinics Universitätsklinikum AKH Wien Departments / AKH Wien (University Hospital Vienna) Institutes and Centers Outpatient departments & services Medical Services Good health and well-being Mediziner:innen kontra Rauchen MedUni Wien-Tipp: Richtiges Händewaschen #expertcheck C … ni Vienna External lecturers Rockfish Bio wins prestigious Science and Business Award 2025 S&B Award: Spin-off from MedUni Vienna/BOKU receives funding from the Rudolf Sallinger Fund Home About us News 2025 News in June 2025 Rockfish Bio wins prestigious Science and Business Award 2025 All News – University , Medicine & Science (Vienna, 03 June 2025) Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candida … Bio's compounds eliminate them without harming healthy cells. With the S&B Award, the Rudolf Sallinger Fund honors early-stage commercialization ideas based on scientific achievement. Preclinical studies have shown remarkable effects, including extension of both lifespan and healthspan and restoration of neuromuscular function, supporting the therapeutic potential of these compounds in promoting healthy aging and treating age-related conditions. “We are honored to receiv … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Ingo Lämmermann, CSO/COO of Rockfish Bio. The award-winning team includes Ingo Lämmermann and Johannes Grillari from BOKU U
Longevity senotherapeutics report: Rockfish Bio – tackling senescence Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search DiamiR, AlzLabs team up … ghlights new GLP-1 care model GARM Clinic debuts world’s first Klotho longevity residency You might also like Scribe lands $25m to advance heart disease gene therapies ŌURA-LillyDirect collab highlights new GLP-1 care model GARM Clinic debuts world’s first Klotho longevity residency NorthStrive eyes emerging GLP-1 opportunity: muscle preservation Stem cell banking partnership targets future of longevity Eleanor Garth Editor Now a science and medicine journalist, Eleanor worke
--> Success Story: Rockfish Bio Wins Two Major Awards – A Showcase of InnovPrecMed’s Innovation Power top of page HOME ABOUT ABOUT THE PROJECT CONSORTIUM WORK PACKAGES NEWS COURSES ACTIVITIES MENTORING INTERNSHIPS RESULTS & SUCCESS STORIES INNOVATION LEADERS CONTACT More Use tab to navigate through the menu items. All Posts Search Success Story: Rockfish Bio Wins Two Major Awards – A Showcase of InnovPrecMed’s Innovation Power juliadankova Nov 21, 2025 1 min read Rockfish Bio, a spin-off emerging from research at LBI Trauma, BOKU University and the Medical University of Vienna, has won two … Vienna, has won two prestigious awards this season: the Science & Business Award 2025 from the Rudolf Sallinger Fund and the BOKU Start-up Award for Healthy Aging. Co-founded by LBI Trauma director and InnovPrecMed member Johannes Grillari and Ingo Lämmermann, Rockfish Bio is developing a new class of senolytic drug candidates that selectively eliminate senescent cells, which drive chronic inflammation and age-related diseases. Their molecules target a unique metabolic s
Proud to join forces with Rockfish Bio! this partnership is a great step forward for senolytic therapy and demonstrates the power of combining our extensive drug discovery expertise and with… | Carol Austin LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
Rockfish Bio – Promoting healthy aging Contact Imprint Data Privacy Contact Imprint Data Privacy PROMOTING HEALTHY AGING with senolytic therapies for age-related diseases IAAC-BASED SENOLYTICS Chronic Kidney Disease Diabetes Cardiovascular Diseases Liver Fibrosis Neurodegenerative Diseases Sarcopenia Immunosenescence Lung Diseases Osteoarthritis Frailty mRNA-BASED SENOLYTICS Miscellaneous Challe … ience | Publications | Press Rockfish Bio wins prestigious Science and Business Award 2025! Rockfish Bio, a spin-off of BOKU and Medical University of Vienna, convinced the jury with its novel senolytic drug candidates, which specifically target and remove senescent cells — aged, dysfunctional cells that accumulate in tissues over time and contribute to chronic diseases. By leveraging a specific metabolic pathway found in these aged cells, Rockfish Bio's compounds elimin … ing and treating age-related conditions. “We are honored to receive the S&B Award. This recognition is a great motivation and validation of our mission to develop effective therapies against aging-related diseases,” said Dr. Ingo Lämmermann, CSO/COO of Rockfish Bio. Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...). We are currently seeking funding, s
ÖGMBT - Szabo-Scandic HandelsgmbH Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2 … news: Read the latest… in Allgemeine News Life Sciences Awards Austria - Deadline: May 27 Life Sciences Awards Austria The Annual… in Mitgliedsnews 18th ÖGMBT Annual Meeting 2026 | FEMS Regional COLLAB & FEBS3+ Meeting, Vienna Registrations Now Open! 18th ÖGMBT Annual… in Mitgliedsnews Zur Newsübersicht Jobbörse University Assistant Prae-Doc (all genders) TU Vienna, Vienna Research position in Microbial polymer production acib GmbH
ÖGMBT - Mitgliedsnews Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual M
%PDF-1.5 %���� 1956 0 obj > endobj xref 1956 40 0000000016 00000 n 0000004705 00000 n 0000004822 00000 n 0000006011 00000 n 0000006822 00000 n 0000007114 00000 n 0000007893 00000 n 0000008229 00000 n 0000008344 00000 n 0000008457 00000 n 0000008773 00000 n 0000009036 00000 n 0000009734 00000 n 0000009998 00000 n 0000010257 00000 n 0000010895 00000 n 0000011227 00000 n 0000011493 00000 n 0000013865 00000 n 0000013992 00000 n 0000024834 00000 n 0000030850 00000 n 0000043735 00000 n 0000054785 00000 n 0000054910 00000 n 0000058434 00000 n 0000058475 00000 n 0000077112 00000 n 0000077153 00000 n 0 … 8504d8e00a2 xmp.did:74bf71b7-8317-db44-86d3-203e9fc446e4 default converted from application/x-indesign to application/pdf Adobe InDesign 17.2 (Macintosh) / 2022-09-29T12:08:54+02:00 application/pdf Adobe PDF Library 16.0.7 False endstream endobj 34 0 obj > endobj 35 0 obj >stream H��V�n�6}/��/-�/��&� {��� 1��-(^ aeQ�������K,o�� �̙����� ߭��"ح˪�I(��5���2��O�i� y_s���m� D֭0 �F- c��W^�P�|�8$s�HWԾ�U��"�? ��N����Uu'��]㝨1��F/����K��yߥY�k��uc7Nj��b���� ��g]�>��g … �tQZPR�I'mr�7lJ|TJ�숍%���)h�H��Ǜz��|T��ʥ W,�v�� O�4_�^vgT��G�2��c>R���rFp}�0n ���SKŒ&�3��3������e6.�c�*�2��p �ͤ�~r8@_���|;;�pKf�0e�vc�|B%`(�^V��l��#Q�.��u�y�,������iSK�'":x�'�l���\1�w�z��W6>:c.��ݴ @�D78��t`{w�~��(����g_~*�R���������9^ �R���4��Y����@���,_8���Vpm��* ��/�mJ�� b��m:� U�� ��s.�P��zo��������[ �\�9t �� �ԟ�ϧq�M�UT�M���C�`[)>��C�6 �V�ʧ�_�2� endstream endobj 75 0 obj >stream ����Adobed��� !! # #!,# … d15c8e2e xmp.id:34cfc6d5-b826-41d2-bdbc-35bfea1816cd proof:pdf 1 converted from application/x-indesign to application/pdf Adobe InDesign 17.1 (Macintosh) / 2022-02-22T12:05:18+01:00 xmp.iid:6b79bbb8-3a38-437c-a06c-d9f3ddd75462 xmp.did:ece02f27-5464-4462-ba8b-fab3d15c8e2e xmp.did:ece02f27-5464-4462-ba8b-fab3d15c8e2e default application/pdf MMC-VTU-Inserat-70x280mm.indd Adobe PDF Library 16.0.5 False PDF/X-4 PDF/X-4 endstream endobj 101 0 obj > endobj 102 0 obj >stream ����Ado … f1-3e4c9c60f29c xmp.did:D07171391577E511A93C9D284759F667 default converted from application/x-indesign to application/pdf Adobe InDesign 17.4 (Windows) / 2022-09-25T21:22:35+02:00 application/pdf Adobe PDF Library 16.0.7 False endstream endobj 143 0 obj > endobj 144 0 obj > endobj 145 0 obj >>>/Subtype/Form>>stream H��M��5��} _�o�U.���X�,X V!
ÖGMBT - Nachbaur Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual Meetin … news: Read the latest… in Allgemeine News Life Sciences Awards Austria - Deadline: May 27 Life Sciences Awards Austria The Annual… in Mitgliedsnews 18th ÖGMBT Annual Meeting 2026 | FEMS Regional COLLAB & FEBS3+ Meeting, Vienna Registrations Now Open! 18th ÖGMBT Annual… in Mitgliedsnews Zur Newsübersicht Jobbörse University Assistant Prae-Doc (all genders) TU Vienna, Vienna Research position in Microbial polymer production acib GmbH … bsp; Empowering early-career researchers: FEBS Letters Best Poster Presentation Prize at the I Young Biochemist Meeting Dr. Vitória Baptista, Junior Ambassador for FEBS Letters and Coordinator of the Portuguese Biochemical Society Junior Section (J-SPB, coordinator of J-SPB in 2025), participated in the I Young Bioc... Read more Vitória da Cunha Baptista PhD Student, University of Minho Interested in becoming a contributor to FEBS Network? Email This emai … ar Senescence 18 June 2026 FEBS3+ Meetings | ÖGMBT 2026 early registration deadline 23 June 2026 FEBS Press | FEBS Letters webinar on Circadian clocks 25 June 2026 FEBS-IUBMB-ENABLE Conference 2026 | Early bird & travel grant deadline 30 June 2026 FEBS Excellence Awards 2026 | Application deadline 15 August 2026 FEBS Press | FEBS Letters cover contest deadline 31 August 2026 FEBS Advanced Courses | 2027 Call for applications 1 September 2026 FEBS3+ Meetings 202 … 027 Call for applications 1 September 2026 FEBS3+ Meetings 2027 | Funding application deadline 30 September 2026 The FEBS Congress 2026: Maastricht awaits For those of you coming to the 50th FEBS Congress , we look forward to welcoming you very soon for five days of immersion, inspiration and international interaction across the mole
ÖGMBT - Institutions Home About Aufgaben und Ziele Geschäftsstelle Vorstand Zweigstellen ÖGMBT - YLSA Working Groups Cell Based Assays, Therapies and Products Institutionelle- und Firmenmitglieder Ehrenmitglieder Internationales Membership Students Regulars Companies Institutions Awards Life Sciences Research Awards Austria Life Sciences PHD Awards Austria Success Stories Best Talk & Poster Prizes Events Annual Meeting Welcome FEMS Regional COLLAB FEBS3+ Registration & Abstract Submission Venue & Travel & Hotel Sponsors & Exhibitors Past Events Annual Meeting 2025 Annual Me … e-newsletter with updates on the field, member activities, jobs, select events, grant deadlines, seminars etc. which can be forwarded to students and researchers Special discounts on online banner ads in Job board Further education board ÖGMBT e-newsletter (sent to > 1.300 members & multipliers) Free subscription to Chemiereport magazine, published 8x/year, 9.000 subscribers (delivered only to addresses in Austria) Possibility to suggest hot topics for the ÖG